Understanding how specific immune cells affect kidney transplant rejection
The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection
This study is looking at how a special kind of immune cell can help prevent the body from rejecting kidney transplants, with the goal of finding new ways to make transplanted kidneys last longer and work better for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10886488 on NIH RePORTER |
What this research studies
This research investigates the role of a specific type of immune cell, known as CD8 regulatory T cells, in controlling antibody-mediated rejection of kidney transplants. By focusing on how these cells interact with T follicular helper cells, which are crucial for B cell differentiation, the study aims to develop new strategies to improve long-term kidney transplant outcomes. The researchers will explore the mechanisms by which these CD8 Tregs regulate immune responses and potentially prevent graft loss. This work could lead to innovative therapies that enhance the survival of transplanted kidneys.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received a kidney transplant and are at risk of antibody-mediated rejection.
Not a fit: Patients who have not undergone kidney transplantation or those with other types of organ transplants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the survival rates of kidney transplants.
How similar studies have performed: Previous research has shown promising results in understanding immune regulation in transplantation, suggesting that this approach could lead to significant advancements.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Azzi, Jamil — Brigham and Women's Hospital
- Study coordinator: Azzi, Jamil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.